Optimize Novel Imaging Biomarkers & Endpoints for Dry AMD Trials

Time: 1:30 pm
day: Track 2 Day 2 PM


  • Review current FAF and OCT biomarkers for AMD progression
  • Discuss endpoints for assessing efficacy in current GA trials
  • Explore novel OCT-A biomarkers for use in clinical research and clinical trials